Joseph G. Pressey · Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial
Follow
Article1 min read·Published Aug 2016Older

Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Aug 2016 · 1 min read

In brief

In brief

This prospective trial compared sentinel lymph node biopsy with SPECT-CT versus PET-CT imaging for detecting nodal metastases in 28 pediatric and AYA sarcoma patients. SLNB identified nodal disease in 25% of patients, including 3 cases missed by PET-CT, while PET-CT showed low positive predictive value (29%) for histologically confirmed metastases.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Background: Lymph node metastases are an important cause of treatment failure for pediatric and adolescent/young adult (AYA) sarcoma patients. Nodal sampling is recommended for certain sarcoma subtypes that have a predilection for lymphatic spread. Sentinel lymph node biopsy (SLNB) may improve the diagnostic yield of nodal sampling, particularly when single-photon emission computed tomography/computed tomography (SPECT-CT) is used to facilitate anatomic localization. Functional imaging with positron emission tomography/computed tomography (PET-CT) is increasingly used for sarcoma staging and is a less invasive alternative to SLNB. To assess the utility of these 2 staging methods, this study prospectively compared SLNB plus SPECT-CT with PET-CT for the identification of nodal metastases in pediatric and AYA patients. Methods: Twenty-eight pediatric and AYA sarcoma patients underwent SLNB with SPECT-CT. The histological findings of the excised lymph nodes were then correlated with preoperative PET-CT imaging. Results: A median of 2.4 sentinel nodes were sampled per patient. No wound infections or chronic lymphedema occurred. SLNB identified tumors in 7 of the 28 patients (25%), including 3 patients who had normal PET-CT imaging of the nodal basin. In contrast, PET-CT demonstrated hypermetabolic regional nodes in 14 patients, and this resulted in a positive predictive value of only 29%. The sensitivity and specificity of PET-CT for detecting histologically confirmed nodal metast

Statements in this article

  1. Lymph node metastases are an important cause of treatment failure for pediatric and adolescent/young adult sarcoma patients.

    EstablishedBackground
  2. Nodal sampling is recommended for certain sarcoma subtypes that have a predilection for lymphatic spread.

    GuidelineBackground
  3. A median of 2.4 sentinel nodes were sampled per patient.

    ResearchResults
  4. No wound infections or chronic lymphedema occurred following sentinel lymph node biopsy.

    ResearchResults
  5. Sentinel lymph node biopsy identified tumors in 7 of 28 patients (25%).

    ResearchResults
  6. Sentinel lymph node biopsy identified nodal metastases in 3 patients who had normal PET-CT imaging of the nodal basin.

    ResearchResults
  7. PET-CT demonstrated hypermetabolic regional nodes in 14 patients.

    ResearchResults
  8. PET-CT had a positive predictive value of only 29% for detecting nodal metastases.

    ResearchResults

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.